Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Understand the key risks the SP 500 presents to retirees and how volatility can impact withdrawal plans and long-term goals. This intro covers market exposure and practical safeguards.
17,139 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Avantis U.S. Large Cap Value ETF (AVLV) has outpaced peers with a profitability-driven screen, posting a 24.5% gain o...
A dramatic drop from a recent high has investors debating whether Nuscale Power represents a buying opportunity or a ...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
SpaceX dazzled investors at IPO, but the price soon drifted below debut. This article shows how a $10,000 investment ...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
Ron Paul challenges President Trump’s move to hold government stakes in private companies, arguing it threatens liber...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
A major institution disclosed a sizable stake in the Akre Focus ETF, signaling strong conviction in a concentrated gr...
Energy markets pivot as renewables rise and fossil fuels adapt; several penny stocks are drawing attention for their ...
Nu Holdings surprised markets with strong revenue growth, yet its stock plummeted this week amid expansion anxieties ...